ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 72 filers reported holding ESSA PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,247,120 | +16.8% | 4,287,094 | +2.0% | 1.22% | -3.1% |
| Q2 2023 | $11,345,654 | -7.8% | 4,202,094 | +1.4% | 1.26% | -1.1% |
| Q1 2023 | $12,310,997 | +26.3% | 4,145,117 | +7.1% | 1.28% | -8.9% |
| Q4 2022 | $9,750,868 | +102.9% | 3,869,392 | +46.5% | 1.40% | +114.2% |
| Q3 2022 | $4,806,000 | -63.4% | 2,640,539 | -36.7% | 0.65% | -68.1% |
| Q2 2022 | $13,132,000 | -49.7% | 4,168,799 | -1.3% | 2.05% | -39.2% |
| Q1 2022 | $26,103,000 | -47.9% | 4,223,799 | +19.8% | 3.37% | -32.8% |
| Q4 2021 | $50,061,000 | +118.2% | 3,525,457 | +22.9% | 5.01% | +40.2% |
| Q3 2021 | $22,944,000 | -64.1% | 2,868,023 | +28.1% | 3.58% | -63.6% |
| Q2 2021 | $63,943,000 | +6.3% | 2,238,104 | +8.1% | 9.83% | -9.2% |
| Q1 2021 | $60,135,000 | +112.2% | 2,070,052 | -12.9% | 10.84% | +189.7% |
| Q4 2020 | $28,342,000 | +124.8% | 2,375,681 | +30.0% | 3.74% | -44.0% |
| Q3 2020 | $12,606,000 | -2.3% | 1,826,980 | -12.3% | 6.68% | -9.2% |
| Q2 2020 | $12,909,000 | +55.1% | 2,082,185 | +0.1% | 7.36% | -24.0% |
| Q1 2020 | $8,322,000 | -7.4% | 2,080,421 | +27.3% | 9.68% | +11.7% |
| Q4 2019 | $8,989,000 | – | 1,634,369 | – | 8.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |